Yan L. Gui

Key Laboratory Of Integrated Precision Diagnosis And Treatment For Solid Tumors
Nanchong, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Serial CSF CA19-9 monitoring and CSF genomic profiling in ERBB2-mutant lung adenocarcinoma with leptomeningeal metastasis: a case report.

Serial CSF CA19-9 monitoring and CSF genomic profiling in ERBB2-mutant lung adenocarcinoma with leptomeningeal metastasis: a case report.

Journal: Frontiers in oncology

Published: July 01, 2026

Osteopontin Promotes Lung Cancer Growth through NF-κB-Dependent Upregulation of PD-L1 and Suppression of Anti-Tumor Immunity.

Osteopontin Promotes Lung Cancer Growth through NF-κB-Dependent Upregulation of PD-L1 and Suppression of Anti-Tumor Immunity.

Journal: Molecular biology reports

Published: March 07, 2026

The FGD5-AS1/miR-142-5p/CDK5 axis promotes ESCC progression by regulating mitochondrial fission and mitophagy: insights from integrative bioinformatics and experimental analyses.

The FGD5-AS1/miR-142-5p/CDK5 axis promotes ESCC progression by regulating mitochondrial fission and mitophagy: insights from integrative bioinformatics and experimental analyses.

Journal: World journal of surgical oncology

Published: December 11, 2025

Impact of Evolving Antiemetic Prophylaxis on Chemotherapy-Induced Nausea and Vomiting (CINV): A Five-Year Comparative Study in Sichuan, China (2018-2023).

Impact of Evolving Antiemetic Prophylaxis on Chemotherapy-Induced Nausea and Vomiting (CINV): A Five-Year Comparative Study in Sichuan, China (2018-2023).

Journal: Cancer management and research

Published: December 03, 2025

Chemoradiotherapy versus Chemotherapy Alone in Extensive-Stage Small Cell Esophageal Carcinoma: A Multicenter Retrospective Study Highlighting the Role of Radiotherapy (ChiSCEC).

Chemoradiotherapy versus Chemotherapy Alone in Extensive-Stage Small Cell Esophageal Carcinoma: A Multicenter Retrospective Study Highlighting the Role of Radiotherapy (ChiSCEC).

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: November 03, 2025

Preliminary exploration of the optimal timing of chemoimmunotherapy combined with radiotherapy for oligometastatic esophageal squamous cell carcinoma and analysis of prognostic factors: a multicenter retrospective study.

Preliminary exploration of the optimal timing of chemoimmunotherapy combined with radiotherapy for oligometastatic esophageal squamous cell carcinoma and analysis of prognostic factors: a multicenter retrospective study.

Journal: Frontiers in oncology

Published: October 28, 2025

Radiotherapy dose may not affect prognosis in ESCC patients receiving first-line chemoradiotherapy-immunotherapy: A multicenter retrospective study.

Radiotherapy dose may not affect prognosis in ESCC patients receiving first-line chemoradiotherapy-immunotherapy: A multicenter retrospective study.

Journal: Cancer immunology, immunotherapy : CII

Published: September 18, 2025

Furmonertinib in lung adenocarcinoma with EGFR exon 20 insertion mutation: A case report of positive outcome.

Furmonertinib in lung adenocarcinoma with EGFR exon 20 insertion mutation: A case report of positive outcome.

Journal: Medicine

Published: July 14, 2025

The Integration of Olink Proteomics with Transcriptomics Elucidates that TNF-α Induces Senescence and Apoptosis in Transplanted Mesenchymal Stem Cells.

The Integration of Olink Proteomics with Transcriptomics Elucidates that TNF-α Induces Senescence and Apoptosis in Transplanted Mesenchymal Stem Cells.

Journal: Stem cell reviews and reports

Published: July 06, 2025

Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355).

Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355).

Journal: Frontiers in immunology

Published: May 23, 2025

Emerging photothermal agents combined with immunotherapy for cancer treatment.

Emerging photothermal agents combined with immunotherapy for cancer treatment.

Journal: Discover oncology

Published: May 06, 2025

Case Report: Cadonilimab plus anlotinib with radiotherapy for lung adenocarcinoma with pancreatic metastasis in later-line therapy.

Case Report: Cadonilimab plus anlotinib with radiotherapy for lung adenocarcinoma with pancreatic metastasis in later-line therapy.

Journal: Frontiers in immunology

Published: April 12, 2025

Showing 1-12 of 33

Last Updated: 09/26/2026